Entering text into the input field will update the search result below

Ginkgo extends gains with a 21% rise as Street reacts to Q2 results

Business on Wall Street in Manhattan

Pgiam/iStock via Getty Images

The shares of cell programming platform company Ginkgo Bioworks (NYSE:DNA) continued to trade higher in the pre-market Tuesday with a ~21% rise as Wall Street responded to its Q2 2022 financials, which included a

Recommended For You

About DNA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
DNA--
Ginkgo Bioworks Holdings, Inc.